Literature DB >> 15363438

Veterinary anthelmintics: old and new.

Quintin A McKellar1, Frank Jackson.   

Abstract

Between 1960 and 1980, extraordinary success was achieved in anthelmintic development for animals. In these 20 years, drugs with diverse structure, novel activity and enviable safety were produced for a global livestock industry leading to the productivity gains needed to support a human population that grew by 1.5 billion during the same period. The following 20 years have been spent refining existing molecules with niche activity (parasite and host specificity), improving delivery systems and worrying about the inexorable spread of drug resistance. The challenge for the next 20 years will be to use the technologies available to design and produce new drugs and biological controls. Then, to use the lessons of the past to ensure that the new drugs enjoy a longer useful lifespan and contribute to an animal health industry (livestock and companion) which enriches the lives of a global population. Old and new veterinary anthelmintics comprise a very large field, which could not be comprehensively reviewed in a short article. The present mini-review focuses on major chemical discoveries, formulation developments, administration strategies and new products.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363438     DOI: 10.1016/j.pt.2004.08.002

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  26 in total

Review 1.  Nematode phospholipid metabolism: an example of closing the genome-structure-function circle.

Authors:  Soon Goo Lee; Joseph M Jez
Journal:  Trends Parasitol       Date:  2014-03-28

Review 2.  Ion channels and receptor as targets for the control of parasitic nematodes.

Authors:  Adrian J Wolstenholme
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-10-14       Impact factor: 4.077

3.  An insect-tapeworm model as a proxy for anthelminthic effects in the mammalian host.

Authors:  Ian David Woolsey; Brian L Fredensborg; Per M Jensen; Christian M O Kapel; Nicolai V Meyling
Journal:  Parasitol Res       Date:  2015-04-18       Impact factor: 2.289

4.  Anthelmintic screening of fractions of Elephantorrhiza elephantina root extract against Haemonchus contortus.

Authors:  Viola Maphosa; Patrick J Masika
Journal:  Trop Anim Health Prod       Date:  2011-06-04       Impact factor: 1.559

5.  A purified Bacillus thuringiensis crystal protein with therapeutic activity against the hookworm parasite Ancylostoma ceylanicum.

Authors:  Michael Cappello; Richard D Bungiro; Lisa M Harrison; Larry J Bischof; Joel S Griffitts; Brad D Barrows; Raffi V Aroian
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-27       Impact factor: 11.205

6.  Selective effect of the anthelmintic bephenium on Haemonchus contortus levamisole-sensitive acetylcholine receptors.

Authors:  Claude L Charvet; Alan P Robertson; Jacques Cabaret; Richard J Martin; Cédric Neveu
Journal:  Invert Neurosci       Date:  2012-04-24

7.  Use of selamectin and moxidectin in the treatment of mouse fur mites.

Authors:  Deborah M Mook; Kimberly A Benjamin
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-05       Impact factor: 1.232

8.  Proteomic profiling and protein identification by MALDI-TOF mass spectrometry in unsequenced parasitic nematodes.

Authors:  Paul Millares; E James Lacourse; Samirah Perally; Deborah A Ward; Mark C Prescott; Jane E Hodgkinson; Peter M Brophy; Huw H Rees
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

9.  A highly conserved, inhibitable astacin metalloprotease from Teladorsagia circumcincta is required for cuticle formation and nematode development.

Authors:  Gillian Stepek; Gillian McCormack; Alan D Winter; Antony P Page
Journal:  Int J Parasitol       Date:  2015-02-28       Impact factor: 3.981

10.  An extensive comparison of the effect of anthelmintic classes on diverse nematodes.

Authors:  Yan Hu; Brian L Ellis; Ying Y Yiu; Melanie M Miller; Joseph F Urban; Linda Z Shi; Raffi V Aroian
Journal:  PLoS One       Date:  2013-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.